Human T-cell leukemia virus specific antigens.

Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Human T-cell leukemia virus specific antigens.

Princess Takamatsu Symp. 1984;15:197-203. Unique Identifier : AIDSLINE MED/86111561
Lee TH; Coligan JE; Essex M

Abstract: Type I and type II human T-cell leukemia viruses (HTLV) contain in their genomes three structural genes, gag, pol, and env and a putative transforming gene, lor. Using a living cell membrane immunofluorescence assay, antibodies to surface-expressed env gene products of HTLV-MA have been detected in healthy carriers living in the HTLV-I endemic areas, and in patients with adult T-cell leukemia/lymphoma (ATLL). Similar antibody reactivities were detected in patient MO, from whom HTLV-II was first isolated, and in a proportion of patients with acquired immune deficiency syndrome (AIDS). Amino acid sequence homology between env gene products of HTLV-I and HTLV-II provides the molecular basis for the observed serological crossreactivity. Detection of HTLV-specific antibody in a proportion of AIDS patients suggested that agents related to HTLV-I may be the etiological cause of AIDS. Several lines of evidence have now suggested that HTLV-III is the etiological agent of AIDS. Flanked by the env gene and 3' long terminal repeat (LTR) is a region originally described by Seiki et al. as X. A 42 kdalton and a 38 kdalton product have been detected in HTLV-I and HTLV-II transformed cells, respectively. These two proteins appear to be translated from a long open reading (lor) frame in the X region, and from a yet to be defined region upstream to the lor gene. The identification of lor products provides direct evidence for the presence of previously unidentified functional genes in HTLV-I and HTLV-II.(ABSTRACT TRUNCATED AT 250 WORDS)

Keywords: Antigens, Viral/*ANALYSIS Glycoproteins/ANALYSIS Human HTLV-BLV Viruses/*IMMUNOLOGY Leukemia/MICROBIOLOGY Membrane Proteins/IMMUNOLOGY Nucleoproteins/ANALYSIS Peptides/ANALYSIS Phosphoproteins/ANALYSIS Polymorphism (Genetics) T-Lymphocytes Viral Proteins/IMMUNOLOGY JOURNAL ARTICLE REVIEW

860530
M8650232

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .